AirSculpt Technologies, Inc. focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of October 5, 2021, it operated 16 centers across 13 states. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
IPO Year: 2021
Exchange: NASDAQ
Website: elitebodysculpture.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/17/2024 | Neutral | BTIG Research | |
| 5/14/2024 | $8.25 → $5.00 | Outperform → Market Perform | Leerink Partners |
| 11/11/2022 | $4.00 | Overweight → Neutral | Piper Sandler |
| 6/16/2022 | $17.00 → $8.50 | Overweight → Equal-Weight | Morgan Stanley |
| 11/23/2021 | $18.00 | Outperform | Raymond James |
| 11/23/2021 | $17.00 | Overweight | Morgan Stanley |
| 11/23/2021 | $26.00 | Outperform | SVB Leerink |
| 11/23/2021 | $22.00 | Overweight | Piper Sandler |
144 - Airsculpt Technologies, Inc. (0001870940) (Subject)
144 - Airsculpt Technologies, Inc. (0001870940) (Subject)
10-Q - Airsculpt Technologies, Inc. (0001870940) (Filer)
8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)
8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)
8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)
S-8 - Airsculpt Technologies, Inc. (0001870940) (Filer)
10-Q - Airsculpt Technologies, Inc. (0001870940) (Filer)
8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)
8-K - Airsculpt Technologies, Inc. (0001870940) (Filer)
SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Filed by)
SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
3 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
MIAMI BEACH, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the third quarter and nine months ended September 30, 2024. "Our revenue and Adjusted EBITDA for the quarter were in line with our expectations with the period including progress on our strategy despite continued challenges in the consumer environment," said Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer of AirSculpt Technologies, Inc. "We are pleased with our four new center openings during the quarter and our 2023 de novo class continues to surpass ou
Expects 2024 Revenue in the Range of $183 Million to $189 Million Announces Third Quarter Fiscal 2024 Earnings Date and Conference Call MIAMI BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced selected unaudited preliminary financial results for its third quarter ended September 30, 2024. For the third quarter, revenue is expected to be approximately $42.5 million, a decrease of approximately 9% over the prior year. Same store cases declined 8.1% over the prior year period. "While we continue to see top line pressures primarily from macro-econo
MIAMI BEACH, Fla., Oct. 1, 2024 /PRNewswire/ -- AirSculpt® Technologies, Inc., ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced the opening of its Birmingham office at 555 S. Old Woodward Avenue Suite 500, Birmingham, MI 48009, increasing its center count to 31 locations. The center has been artfully designed and is complete with two operating rooms allowing for concurrent procedures. Also, the company's popular AirSculpt®+ skin tightening procedure has been brought to the clinic's list of offerings. "We are ex
MIAMI BEACH, Fla., Sept. 24, 2024 /PRNewswire/ -- AirSculpt® Technologies, Inc., ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced the opening of its Deerfield office at 720 Waukegan Rd Suite 200, Deerfield, IL 60015 conveniently located within Deerfield Square, an upscale, lifestyle shopping center. The addition of this location increases AirSculpt's center count to 30 locations. The center has been artfully designed and is complete with three operating rooms allowing for concurrent procedures. Also, the company
MIAMI BEACH, Fla., Aug. 19, 2024 /PRNewswire/ -- AirSculpt® Technologies, Inc., ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced the opening of its Columbus office at 4100 Regent St Suite 4-H, Columbus, OH 42319, increasing its center count to 29 locations. The center has been artfully designed and is complete with two operating rooms allowing for concurrent procedures. Also, the company's popular AirSculpt®+ skin tightening procedure has been brought to the clinic's list of offerings. "We're thrilled to bring
Second Quarter Revenue of $51.0 million, Net Loss of $3.2 million and Adjusted EBITDA of $6.9 million Company Revises 2024 Guidance MIAMI, Aug. 09, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the second quarter and first six months ended June 30, 2024. The Company also announced that Dennis Dean, Chief Financial Officer of the Company has assumed the position of Interim Chief Executive Officer as Todd Magazine has resigned from the Chief Executive Officer role and as a member of the Board of Directors. Mr. Magazine
MIAMI BEACH, Fla., Aug. 09, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced Todd Magazine has stepped down from his role as Chief Executive Officer and as a member of the Board of Directors of the Company. Mr. Magazine will serve as an advisor to the Company through December 31, 2024. Dennis Dean, Chief Financial Officer has assumed the position of interim Chief Executive Officer until a permanent successor is named. Dr. Aaron Rollins, Executive Chairman of the Board stated: "I am confident in our business model and see tremendous opportunity to expand upon our Com
MIAMI BEACH, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), a national provider of premium body contouring procedures, today announced it will report second quarter 2024 financial results before market open on Friday, August 9, 2024, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13747871 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt Techn
MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2024. First Quarter Cases increased 2.9% over the prior year period to 3,746Revenue increased 3.9% over the prior year to $47.6 millionNet income of $6.0 million for the quarter compared to $(0.0) million in the prior year periodDiluted income per share for the quarter of $0.10Six planned openings in 2024 "We grew revenues about 4% in the quarter driven by the de novo locations we opened in the prior year. These centers continue to outpace our
MIAMI BEACH, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), a national provider of premium body contouring procedures, today announced it will report first quarter 2024 financial results before market open on Friday, May 10, 2024, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13745132 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt Technol
MIAMI BEACH, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the third quarter and nine months ended September 30, 2024. "Our revenue and Adjusted EBITDA for the quarter were in line with our expectations with the period including progress on our strategy despite continued challenges in the consumer environment," said Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer of AirSculpt Technologies, Inc. "We are pleased with our four new center openings during the quarter and our 2023 de novo class continues to surpass ou
Expects 2024 Revenue in the Range of $183 Million to $189 Million Announces Third Quarter Fiscal 2024 Earnings Date and Conference Call MIAMI BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced selected unaudited preliminary financial results for its third quarter ended September 30, 2024. For the third quarter, revenue is expected to be approximately $42.5 million, a decrease of approximately 9% over the prior year. Same store cases declined 8.1% over the prior year period. "While we continue to see top line pressures primarily from macro-econo
Second Quarter Revenue of $51.0 million, Net Loss of $3.2 million and Adjusted EBITDA of $6.9 million Company Revises 2024 Guidance MIAMI, Aug. 09, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the second quarter and first six months ended June 30, 2024. The Company also announced that Dennis Dean, Chief Financial Officer of the Company has assumed the position of Interim Chief Executive Officer as Todd Magazine has resigned from the Chief Executive Officer role and as a member of the Board of Directors. Mr. Magazine
MIAMI BEACH, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), a national provider of premium body contouring procedures, today announced it will report second quarter 2024 financial results before market open on Friday, August 9, 2024, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13747871 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt Techn
MIAMI BEACH, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2024. First Quarter Cases increased 2.9% over the prior year period to 3,746Revenue increased 3.9% over the prior year to $47.6 millionNet income of $6.0 million for the quarter compared to $(0.0) million in the prior year periodDiluted income per share for the quarter of $0.10Six planned openings in 2024 "We grew revenues about 4% in the quarter driven by the de novo locations we opened in the prior year. These centers continue to outpace our
MIAMI BEACH, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), a national provider of premium body contouring procedures, today announced it will report first quarter 2024 financial results before market open on Friday, May 10, 2024, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13745132 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt Technol
MIAMI BEACH, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the fourth quarter and full year ended December 31, 2023. Fourth quarter revenue increased 17.0% to $47.6 million and full year increased 16.1% to $195.9 million from the prior year periodsFourth quarter net loss improved $2.6 million to $4.6 million and full year net loss improved $10.2 million to $4.5 million loss as compared to the prior year periodsFourth quarter adjusted EBITDA rose 27.9% to $10.1 million, and full year adjusted EBITDA rose 11.2% to $43.2 million, from the
MIAMI BEACH, Fla., Jan. 31, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), a national provider of premium body contouring procedures, today announced it will report fourth quarter 2023 financial results before market open on Tuesday, February 27, 2024, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13743630 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt T
MIAMI BEACH, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the third quarter ended September 30, 2023. Cases increased 19.0% over the prior year period to 3,426Revenue increased 20.3% over the prior year to $46.8 millionNet loss of $(1.7) million for the quarter compared to $(7.4) million in the prior year periodDiluted loss per share for the quarter of $(0.03)Diluted adjusted net income per share for the quarter of $0.05Opened facilities in San Jose, CA and Raleigh, NC "I am pleased with our performance for the third quarter reflectin
MIAMI BEACH, Fla., Oct. 27, 2023 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. ("AirSculpt") (NASDAQ:AIRS), a national provider of premium body contouring procedures, today announced it will report third quarter 2023 financial results before market open on Friday, November 10, 2023, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13741347 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt Tec
BTIG Research initiated coverage of AirSculpt Technologies with a rating of Neutral
Leerink Partners downgraded AirSculpt Technologies from Outperform to Market Perform and set a new price target of $5.00 from $8.25 previously
Piper Sandler downgraded AirSculpt Technologies from Overweight to Neutral and set a new price target of $4.00
Morgan Stanley downgraded AirSculpt Technologies from Overweight to Equal-Weight and set a new price target of $8.50 from $17.00 previously
Raymond James initiated coverage of AirSculpt Technologies with a rating of Outperform and set a new price target of $18.00
Morgan Stanley initiated coverage of AirSculpt Technologies with a rating of Overweight and set a new price target of $17.00
SVB Leerink initiated coverage of AirSculpt Technologies with a rating of Outperform and set a new price target of $26.00
Piper Sandler initiated coverage of AirSculpt Technologies with a rating of Overweight and set a new price target of $22.00
Leerink Partners analyst Whit Mayo downgrades AirSculpt Technologies (NASDAQ:AIRS) from Outperform to Market Perform and announces $5 price target.
AirSculpt Technologies (NASDAQ:AIRS) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.02) by 250 percent. This is a 70 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $47.62 million which missed the analyst consensus estimate of $49.80 million by 4.38 percent. This is a 3.94 percent increase over sales of $45.81 million the same period last year.
U.S. stocks were lower, with the Dow Jones index falling over 50 points on Wednesday. Shares of United Airlines Holdings, Inc. (NASDAQ:UAL) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter financial results. Revenue of $12.539 billion topped estimates of $12.4 billion. The company posted a loss of 15 cents per share, versus expectations for a loss of 57 cents per share, according to data from Benzinga Pro. United Airlines shares jumped 11.2% to $46.12 on Wednesday. Here are some other big stocks recording losses in today’s session. Edible Garden AG Incorporated (NASDAQ:EDBL) surged 112% to $9.73 after the company reported prelimin
The company expects Adjusted EBITDA of approximately $50 million, Six new centers to open in the second half of 2024
AirSculpt Technologies (NASDAQ:AIRS) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 50 percent. The company reported quarterly sales of $47.61 million which missed the analyst consensus estimate of $48.07 million by 0.96 percent. This is a 16.96 percent increase over sales of $40.70 million the same period last year.
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. • American Electric Power (NASDAQ:AEP) is projected to report quarterly earnings at $1.26 per share on revenue of $5.12 billion. • Quanterix (NASDAQ:QTRX) is expected to report quarterly loss at $0.32 per share on revenue of $29.84 million. • Pinnacle West Capital (NYSE:PNW) is expected to report quarterly loss at $0.13 per share on revenue of $1.12 billion. • Cracker Barrel Old (NASDAQ:CBRL) is expected to report quarterly earnings at $1.37 per share on revenue of $917.33 million. • PAR Technology (NYSE:PAR) is projected to report quart
Fuzzy Panda Research has hit AirSculpt Technologies Inc (NASDAQ:AIRS), a company focused on providing body contouring (liposuction) procedures in the U.S. The report highlights a series of practices that raise serious concerns about the safety and credibility of the plastic surgery company. Founder Dr. Aaron Rollins has marketed the company’s fat removal/transfer procedure as a safe alternative, comparing the risk to getting a tooth pulled. However, Fuzzy report notes that the investigation has uncovered a different reality. The investigation revealed instances where the AirSculpt procedure was linked to the “cause of death” of a 37-year-old mother, contradicting the company’s
https://fuzzypandaresearch.com/airs/ Multiple Malpractice Lawsuits Uncovered including AirSculpt Causing a Patient Death Uncovered Doctors that have Sanctioned by State Medical Boards and/or that Lie About CredentialsAdvertising Practices in Violation of FTC RulesMisleading Technology ClaimsPatient Images that Are Photoshopped AirSculpt Technologies (AIRS) is a public plastic surgery company that promises patients a safer, less-invasive fat removal/transfer procedure via their "exclusively available" and "patented technology." AirSculpt's Founder Dr. Aaron Rollins claims the risk is "roughly equivalent to getting a tooth pulled." We are short AirSculpt. We discovered the truth that AirSculpt
Morgan Stanley has decided to maintain its Equal-Weight rating of AirSculpt Technologies (NASDAQ:AIRS) and lower its price target from $8.00 to $6.00. Shares of AirSculpt Technologies are trading up 7.18% over the last 24 hours, at $5.52 per share. A move to $6.00 would account for a 8.7% increase from the current share price. About AirSculpt Technologies AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under our brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic resu